4th TIGIT Axis Therapies Digital Summit

The 4th TIGIT Axis Therapies Digital Summit is dedicated to deciphering therapeutic targets in the TIGIT axis to validate biomarkers & defining desirable checkpoint combinations.

Key Topics

• Leverage biomarkers to identify patient responders, monitor therapies and delve deeper into drug MoA with Genentech & Case Western Reserve University
• Decipher the TIGIT axis at a mechanistic level and optimize preclinical models with Dana-Farber Cancer Institute, University Hospital Bonn & University of Central Florida
• Optimize Fc gamma receptor engagement with iTeos Therapeutics, and discuss dosing considerations for TIGIT combinations with Gilead Sciences
• Explore the next era of TIGIT axis targeted therapies in preclinical development with Shattuck Labs, Nectin Therapeutics, Compugen & Mereo Biopharma

Who should Attend

• Case Western Reserve University
• Aurigene Discovery Technologies
• Compugen
• Coherus Biosciences
• Genentech
• Dana-Farber Cancer Institute
• GlaxoSmithKline
• Gilead Sciences
• ITeos Therapeutics
• Graphite Bio
• Mereo Biopharma
• Nectin Therapeutics
• Shattuck Labs
• Mayo Clinic
• University of Zurich
• Orion Corporation
• University of Central Florida
• University Hospital Bonn
• And many more!
• University Medical Center Hamburg-Eppendorf